Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (71-80 of 638) with videos related to

Pageof 64
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|October 29, 2011
Control of metabolism by nutrient-regulated nuclear receptors acting in the brainKadiombo Bantubungi, Janne Prawitt, Bart Staels
Biochimica Et Biophysica Acta|November 8, 2011
Roles of PPARs in NAFLD: potential therapeutic targetsAnne Tailleux, Kristiaan Wouters, Bart Staels
Trends in Endocrinology and Metabolism: TEM|April 20, 2012
Thiazolidinediones and PPARγ agonists: time for a reassessmentBertrand Cariou, Bernard Charbonnel, Bart Staels
Current Opinion in Pharmacology|September 16, 2006
PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndromeCatherine Fiévet, Jean-Charles Fruchart, Bart Staels
Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptorsPhilippe Gervois, Jean-Charles Fruchart, Bart Staels
Diabetes, Obesity & Metabolism|April 27, 2010
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidenceVivian A Fonseca, Yehuda Handelsman, Bart Staels
Current Opinion in Lipidology|September 23, 2003
Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and functionGiulia Chinetti, Jean-Charles Fruchart, Bart Staels
Immunological Reviews|October 17, 2014
Macrophage phenotypes in atherosclerosisSophie Colin, Giulia Chinetti-Gbaguidi, Bart Staels
PPAR Research|April 5, 2008
PPARs/RXRs in Cardiovascular Physiology and DiseaseBrian N Finck, Giulia Chinetti, Bart Staels
Molecular Metabolism|October 3, 2020
Dysregulated lipid metabolism links NAFLD to cardiovascular diseaseAudrey Deprince, Joel T Haas, Bart Staels
Pageof 64

Showing results (71-80 of 638) with videos related to

Sort By:
Pageof 64
The Journal of Steroid Biochemistry and Molecular Biology|October 29, 2011
Control of metabolism by nutrient-regulated nuclear receptors acting in the brainKadiombo Bantubungi, Janne Prawitt, Bart Staels
Biochimica Et Biophysica Acta|November 8, 2011
Roles of PPARs in NAFLD: potential therapeutic targetsAnne Tailleux, Kristiaan Wouters, Bart Staels
Trends in Endocrinology and Metabolism: TEM|April 20, 2012
Thiazolidinediones and PPARγ agonists: time for a reassessmentBertrand Cariou, Bernard Charbonnel, Bart Staels
Current Opinion in Pharmacology|September 16, 2006
PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndromeCatherine Fiévet, Jean-Charles Fruchart, Bart Staels
Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptorsPhilippe Gervois, Jean-Charles Fruchart, Bart Staels
Diabetes, Obesity & Metabolism|April 27, 2010
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidenceVivian A Fonseca, Yehuda Handelsman, Bart Staels
Current Opinion in Lipidology|September 23, 2003
Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and functionGiulia Chinetti, Jean-Charles Fruchart, Bart Staels
Immunological Reviews|October 17, 2014
Macrophage phenotypes in atherosclerosisSophie Colin, Giulia Chinetti-Gbaguidi, Bart Staels
PPAR Research|April 5, 2008
PPARs/RXRs in Cardiovascular Physiology and DiseaseBrian N Finck, Giulia Chinetti, Bart Staels
Molecular Metabolism|October 3, 2020
Dysregulated lipid metabolism links NAFLD to cardiovascular diseaseAudrey Deprince, Joel T Haas, Bart Staels
Pageof 64